Dr Reddy’s launch valsartan tablets in the US market
Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90
Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90
It is used for the treatment of advanced colorectal and gastric cancer
Platina 250, 300 & 350 Lamitubes have been recognized by the Association of Plastic Recyclers (APR), USA as meeting or exceeding the strict APR HDPE critical guidance criteria on recyclability
The group now has 324 approvals and has so far filed over 400 ANDAs
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
Express Scripts, a leading pharmacy benefit management organization, will list Viatris labelled biosimilar insulin Glargine as a preferred insulin brand on its National Preferred Formulary (NPF)
Second interchangeable biosimilar product approved by agency
This product will be manufactured at Lupin’s Pithampur facility In India
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
Subscribe To Our Newsletter & Stay Updated